| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/02/2009 | WO2009081168A1 Remote classification of substances |
| 07/02/2009 | WO2009081165A1 Calibrator for immunoassays |
| 07/02/2009 | WO2009081153A2 Electrochemical assays |
| 07/02/2009 | WO2009081140A1 Method to determine lipids |
| 07/02/2009 | WO2009081136A2 Screening |
| 07/02/2009 | WO2009081135A1 Methods and products for identifying strains of bacteria |
| 07/02/2009 | WO2009081069A2 Polyclonal antibody directed against the elastin binding protein and method for obtaining same |
| 07/02/2009 | WO2009080981A2 Method for screening for agents that modulate the activity of the mdm2 ubiquitin ligase and means for implementing said method |
| 07/02/2009 | WO2009080910A2 Method of screening for compounds that can be used for the treatment of respiratory conditions |
| 07/02/2009 | WO2009080852A1 Rplp1-based antitumour compounds |
| 07/02/2009 | WO2009080812A1 Method for in-vitro detecting pathogenic t helper cells and pharmaceutical compositions for treating autoimmune diseases |
| 07/02/2009 | WO2009080811A1 Polypeptide libraries with a predetermined scaffold |
| 07/02/2009 | WO2009080810A1 New polypeptides having affinity for her2 |
| 07/02/2009 | WO2009080779A1 Ceacam1 as a biomarker of psoriasis |
| 07/02/2009 | WO2009080370A1 Protein analysis |
| 07/02/2009 | WO2009080308A1 Means ands methods of processing biological samples |
| 07/02/2009 | WO2009080303A1 Diagnostic in vitro method for assessing von willebrand disease and increased bleeding risk associated with von willebrand disease and acquired or congenital disorders of platelet function |
| 07/02/2009 | WO2009080302A1 Mhc rapid assay used for the customization of odours |
| 07/02/2009 | WO2009080278A1 Stability testing of antibodies |
| 07/02/2009 | WO2009080219A1 Prediction of genotoxicity |
| 07/02/2009 | WO2009080049A1 Monitoring oil condition and/or quality, on-line or at-line, based on chemometric data analysis of flourescence and/or near infrared spectra |
| 07/02/2009 | WO2009079922A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof |
| 07/02/2009 | WO2009079857A1 A reactor for the quantitative analysis of nucleic acids |
| 07/02/2009 | WO2009079793A1 Non-aggregating human vh domains |
| 07/02/2009 | WO2009079773A1 Method for assessing risk of heart failure |
| 07/02/2009 | WO2009079768A1 Methods of inhibiting tumor growth using ttk antagonists |
| 07/02/2009 | WO2009079762A1 Diagnostic test for cardiomyopathy |
| 07/02/2009 | WO2009079689A1 Analytical method and apparatus |
| 07/02/2009 | WO2009060358A3 Method for detecting redispersion of beads |
| 07/02/2009 | WO2009058898A3 Method and apparatus for diagnoses of hemangiosarcoma in mammals |
| 07/02/2009 | WO2009056762A3 Biochemical test for confirming the presence of l. monocytogenes |
| 07/02/2009 | WO2009055052A3 Improved methods and devices for cellular analysis |
| 07/02/2009 | WO2009052519A3 Co-polymer stabilizers for hydrofluoroalkane dispersions |
| 07/02/2009 | WO2009052179A3 Feline pancreatic lipase |
| 07/02/2009 | WO2009045389A3 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 07/02/2009 | WO2009042639A3 Method for creating perfusable microvessel systems |
| 07/02/2009 | WO2009039542A3 Methods of screening for compounds having anti- inflammatory activity and/or prevent / treat vascular leak |
| 07/02/2009 | WO2009039286A3 Frameless multiplexed microarrays |
| 07/02/2009 | WO2009036149A9 Methods for treatment of degenerative disease associated with apoptosis |
| 07/02/2009 | WO2009034562A3 A method of assessing lung squamous cell carcinoma status in an individual |
| 07/02/2009 | WO2008150832A8 Assay methods for identifying agents that modify the activity of nape-pld or abh4 |
| 07/02/2009 | WO2008058380A8 Cancerous disease modifying antibodies |
| 07/02/2009 | WO2008045344A8 Methods to determine responsiveness to cisplatin treatment |
| 07/02/2009 | WO2008031009A3 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 07/02/2009 | WO2007141005A8 Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target |
| 07/02/2009 | US20090172828 Bydv mp is a viral determinant responsible for plant growth retardation |
| 07/02/2009 | US20090172827 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases |
| 07/02/2009 | US20090172826 Model System for TCR (ZETA) Chain Downregulation |
| 07/02/2009 | US20090171639 Method to identify modulators for human 3alpha-hydroxysteroid dehydrogenase |
| 07/02/2009 | US20090171595 Automatic System for Monitoring the Mixing of Conglomerates |
| 07/02/2009 | US20090171591 Methods for classification of somatic embryos comprising hyperspectral line imaging |
| 07/02/2009 | US20090171070 Process for the Purification of Recombinant Albumin |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170796 Histone Demethylation Mediated By The Nuclear Amine Oxidase Homolog LSD1 |
| 07/02/2009 | US20090170793 Theophylline-dependent riboswitches which modulate RNA splicing; made by insertion of a high affinity theophylline binding aptamer into the 3' splice site region, 5' splice site region, or branchpoint sequence (BPS) of a pre-mRNA modulates RNA splicing in the presence of theophylline |
| 07/02/2009 | US20090170773 Novel use of g-protein-conjugated receptor and ligand thereof |
| 07/02/2009 | US20090170771 Anti-angiogenic agents and methods of their use |
| 07/02/2009 | US20090170765 Peptide for inhibition of calcineurin |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170749 Novel Compounds Which Interact With PEA-15 |
| 07/02/2009 | US20090170728 Methods for detecting target analytes and enzymatic reactions |
| 07/02/2009 | US20090170722 Methods of constructing and screening diverse expression libraries |
| 07/02/2009 | US20090170720 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
| 07/02/2009 | US20090170220 Bispecific capturing molecule |
| 07/02/2009 | US20090170219 Nucleic acid capable of binding to immunoglobulin G and use thereof |
| 07/02/2009 | US20090170218 Methods for detection of cyclosporin a |
| 07/02/2009 | US20090170208 Biomarkers for ovarian cancer |
| 07/02/2009 | US20090170207 Reference ph sensor, preparation and application thereof |
| 07/02/2009 | US20090170201 Compositions and methods of making embryonic stem cells |
| 07/02/2009 | US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 07/02/2009 | US20090170188 for blood glucose or cholesterol level monitoring; two support layers for receiving the sample and viewing the indicator; two operative layers to receive and react with the sample; improved reliability |
| 07/02/2009 | US20090170161 GDEP Enhancer Element and Use Thereof to Confer Retinal Specific Gene Expression |
| 07/02/2009 | US20090170158 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/02/2009 | US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof |
| 07/02/2009 | US20090170138 DETERMINING CANINE proBNP |
| 07/02/2009 | US20090170137 DETERMINING CANINE proBNP |
| 07/02/2009 | US20090170136 DETERMINING FELINE proBNP |
| 07/02/2009 | US20090170135 DETERMINING FELINE proBNP |
| 07/02/2009 | US20090170134 Bifunctional and trifunctional nitrone spin trapping compounds and uses thereof |
| 07/02/2009 | US20090170133 Intact IGFBP-3 as a Colon Cancer Risk Factor in Patients With Inflammatory Bowel Disease |
| 07/02/2009 | US20090170132 Methods for detecting colon carcinoma |
| 07/02/2009 | US20090170131 Agents for Imaging Apoptosis |
| 07/02/2009 | US20090170130 Phosphospecific Chemokine Receptor Antibodies |
| 07/02/2009 | US20090170129 Detection of circulating endothelial cells |
| 07/02/2009 | US20090170128 using crystals of C2 symmetry in drug screening assays comprising selecting a potential modifier by adding the potential modifiers to an aqueous mixture of the crystal and detecting a measure of binding, such that the potential modifier that binds is selected as a potential drug |
| 07/02/2009 | US20090170127 Identifying modulators of chloride channel CIC-7 for use in treatment of bone resorption disorders |
| 07/02/2009 | US20090170126 Prostasin Partial Peptide and Anti-Prostasin Antibody |
| 07/02/2009 | US20090170125 Cellular assay method for identifying pkc-0 inhibitors |
| 07/02/2009 | US20090170124 Hydrogel thin film for use as a biosensor |
| 07/02/2009 | US20090170123 Identification of Novel Protein Targets on the Surface of Stressed Cells |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090170121 Assay buffer, compositions containing the same, and methods of using the same |
| 07/02/2009 | US20090170120 Clinical Correlates |
| 07/02/2009 | US20090170119 Method for amplifying variation of frequency of signal in piezoelectrical biosensor |
| 07/02/2009 | US20090170118 Formation and Encapsulation of Molecular Bilayer and Monolayer Membranes |
| 07/02/2009 | US20090170117 THREE-DIMENSIONAL STRUCTURE OF FabK PROTEIN AND METHOD OF DEVELOPING A FabK PROTEIN INHIBITOR USING THE SAME |
| 07/02/2009 | US20090170116 IL-13 Production Inhibitor |
| 07/02/2009 | US20090170115 Crohn's disease anitbody epitope peptide and reagent for testing crohn's disease |
| 07/02/2009 | US20090170108 Screening method, a composition comprising substances chosen in the method thereof, and a binding substance |
| 07/02/2009 | US20090170102 Methods for detecting dna originating from different individuals |